Simultaneous determination of tolmetin and its metabolite in biological fluids by high-performance liquid chromatography.
A highly sensitive and selective high-performance liquid chromatographic assay has been developed for the separation and quantitation of tolmetin and its major metabolite in human biological fluids, viz. plasma, urine and synovial fluid. Analysis of plasma and synovial fluid required only 0.5 ml of the sample. The sample was washed with diethyl ether and extracted with diethyl ether-chloroform (2:1). The extracted compounds were injected onto a reversed-phase column (RP-2) and absorbance was measured at 313 nm. The standard curves in plasma were found to be linear for both tolmetin and the metabolite at concentrations from 0.04 to 10.0 microgram/ml. Urine samples (0.5 ml) were diluted (1:1) with methanol containing the internal standard and were directly injected onto the reversed-phase (RP-2) column. Standard curves of tolmetin and metabolite in urine were linear in the range 5-300 microgram/ml. Serum and synovial fluid concentrations of tolmetin and its metabolite in patients receiving multiple doses of tolmetin sodium were determined using the assay procedure.
D001172:Arthritis, Rheumatoid / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D011758:Pyrroles / Q000032:analysis* / Q000378:metabolism*; D013582:Synovial Fluid / Q000032:analysis*; D014046:Tolmetin / Q000031:analogs & derivatives / Q000032:analysis* / Q000097:blood / Q000378:metabolism* / Q000652:urine
D011758:Pyrroles; C020402:1-methyl-5-(4-carboxybenzoyl)-1H-pyrrole-2-acetic acid; D014046:Tolmetin